Kimura M, Koida T, Sekihara M
Dept. of Surgery, Gunma Cancer Center, Japan.
Gan To Kagaku Ryoho. 1996 Aug;23(9):1183-5.
A 55-year-old woman with recurrent breast cancer treated with sequential mastectomies, chemo-and hormonal therapy of UFT, CPM and TAM, achieved remission. Six months later she was admitted with a diagnosis of carcinomatous pleurisy. A large pleural effusion was drained followed by administration of ADM, which improved her effusion and accompanying dyspnea. The effusion recurred but the patient desired outpatient treatment. Thus, we prescribed oral 5'-DFUR and MPA. One month later, her cough had improved and her sputum cytology was negative, while on chest radiograph the pleural effusion had decreased and the patch-like shadows in her right lung field had disappeared. She was considered as a case of PR. At one year and 3 months after starting concomitant 5'-DFUR and MPA the pleural effusion disappeared. The patient has received this outpatient treatment for 2 years without adverse reactions.
一名55岁复发性乳腺癌女性患者,接受了序贯乳房切除术、UFT、CPM和TAM的化疗及激素治疗后病情缓解。6个月后,她因癌性胸膜炎入院。引流大量胸腔积液后给予阿霉素治疗,胸腔积液及伴随的呼吸困难得到改善。胸腔积液复发,但患者希望接受门诊治疗。因此,我们开了口服5'-DFUR和甲羟孕酮。1个月后,她的咳嗽有所改善,痰细胞学检查为阴性,胸部X线片显示胸腔积液减少,右肺野的片状阴影消失。她被视为部分缓解病例。在开始联合使用5'-DFUR和甲羟孕酮1年零3个月后,胸腔积液消失。该患者接受这种门诊治疗已2年,未出现不良反应。